NO20062779L - Vaksinesammensetning blandet med en alkylfosfatidylkolin - Google Patents

Vaksinesammensetning blandet med en alkylfosfatidylkolin

Info

Publication number
NO20062779L
NO20062779L NO20062779A NO20062779A NO20062779L NO 20062779 L NO20062779 L NO 20062779L NO 20062779 A NO20062779 A NO 20062779A NO 20062779 A NO20062779 A NO 20062779A NO 20062779 L NO20062779 L NO 20062779L
Authority
NO
Norway
Prior art keywords
alkylphosphatidylcholine
vaccine composition
composition mixed
pharmaceutical composition
additionally contains
Prior art date
Application number
NO20062779A
Other languages
English (en)
Inventor
Jean Haensler
Original Assignee
Sanofi Pasteur
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Pasteur filed Critical Sanofi Pasteur
Publication of NO20062779L publication Critical patent/NO20062779L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/21—Retroviridae, e.g. equine infectious anemia virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/215—Coronaviridae, e.g. avian infectious bronchitis virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A61K39/245—Herpetoviridae, e.g. herpes simplex virus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/545—Medicinal preparations containing antigens or antibodies characterised by the dose, timing or administration schedule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55555—Liposomes; Vesicles, e.g. nanoparticles; Spheres, e.g. nanospheres; Polymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
    • A61K2039/55511—Organic adjuvants
    • A61K2039/55566—Emulsions, e.g. Freund's adjuvant, MF59
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2710/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA viruses
    • C12N2710/00011—Details
    • C12N2710/16011—Herpesviridae
    • C12N2710/16111—Cytomegalovirus, e.g. human herpesvirus 5
    • C12N2710/16134—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2740/00—Reverse transcribing RNA viruses
    • C12N2740/00011—Details
    • C12N2740/10011—Retroviridae
    • C12N2740/16011—Human Immunodeficiency Virus, HIV
    • C12N2740/16311—Human Immunodeficiency Virus, HIV concerning HIV regulatory proteins
    • C12N2740/16334—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Virology (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Microbiology (AREA)
  • Communicable Diseases (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Hematology (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

Sammendrag Oppfinnelsen angår en farmasøytisk sammensetning omfattende minst et vaksineantigen. Sammensetningen kjennetegnes ved at den også omfatter minst et fosforesterderivat av fosfatidylkolin med en struktur med formelen (1) der R, er et lavere alkyl, og R2 og R3 er like eller forskjellige og kan hver representere lineære hydrokarbonkjeder med mellom 13 og 21 karbonatomer.
NO20062779A 2003-11-17 2006-06-14 Vaksinesammensetning blandet med en alkylfosfatidylkolin NO20062779L (no)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR0313406A FR2862306B1 (fr) 2003-11-17 2003-11-17 Composition vaccinale
PCT/FR2004/002911 WO2005049080A1 (fr) 2003-11-17 2004-11-15 Composition vaccinale adjuvantee par une alkylphosphatidylcholine

Publications (1)

Publication Number Publication Date
NO20062779L true NO20062779L (no) 2006-08-15

Family

ID=34508504

Family Applications (1)

Application Number Title Priority Date Filing Date
NO20062779A NO20062779L (no) 2003-11-17 2006-06-14 Vaksinesammensetning blandet med en alkylfosfatidylkolin

Country Status (23)

Country Link
US (2) US7344720B2 (no)
EP (1) EP1696954B1 (no)
JP (1) JP4638880B2 (no)
KR (1) KR101136107B1 (no)
CN (1) CN1882358B (no)
AT (1) ATE412429T1 (no)
AU (1) AU2004290943B2 (no)
BR (1) BRPI0416670A (no)
CA (1) CA2545086C (no)
CY (1) CY1108498T1 (no)
DE (1) DE602004017504D1 (no)
DK (1) DK1696954T3 (no)
ES (1) ES2311875T3 (no)
FR (1) FR2862306B1 (no)
IL (1) IL175573A (no)
LT (1) LT5435B (no)
LV (1) LV13457B (no)
NO (1) NO20062779L (no)
PL (1) PL1696954T3 (no)
PT (1) PT1696954E (no)
SI (1) SI1696954T1 (no)
WO (1) WO2005049080A1 (no)
ZA (1) ZA200603522B (no)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100752990B1 (ko) 2006-08-02 2007-08-30 주식회사 대웅 나노리포좀 및 천연 추출물을 포함하는 피부 질환의 예방또는 치료용 조성물
TWI444384B (zh) * 2008-02-20 2014-07-11 Gilead Sciences Inc 核苷酸類似物及其在治療惡性腫瘤上的用途
CA2716399C (en) 2008-03-05 2020-07-21 Pierre Chouvenc Process for stabilizing an adjuvant containing vaccine composition
WO2010130898A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Vaccin meningocoque a base de lipooligosaccharide (los) provenant de souches modifiees de neisseria meningitidis d'immunotype l6
WO2010130897A1 (fr) * 2009-05-14 2010-11-18 Sanofi Pasteur Procédé de détoxification du lipopolysaccharide (lps) ou du lipide a des bactéries à gram-négatif
WO2010130896A2 (fr) 2009-05-14 2010-11-18 Sanofi Pasteur Procédé pour adjuver le lipopolysaccharide (lps) des bactéries à gram-négatif
EP2578974A1 (en) 2011-10-05 2013-04-10 Sanofi Pasteur Sa Process line for the production of freeze-dried particles
JP5761143B2 (ja) * 2011-11-02 2015-08-12 株式会社リコー 撮像ユニット、撮像ユニットを搭載した車両
US20140147475A1 (en) * 2012-11-29 2014-05-29 Antonius Arnoldus Christiaan Jacobs Vaccine to protect a ruminant against pneumonia caused by pasteurella multocida
BR112015023870A2 (pt) 2013-03-18 2017-07-18 Intervet Int Bv vacina, uso de bactérias atenuadas vivas, método para proteger um ruminante contra pneumonia, e, bactérias atenuadas vivas
EP3171954B1 (en) 2014-07-21 2018-06-27 Sanofi Pasteur SA Liquid feeding device for the generation of droplets and its use for producing a vaccine composition

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6100064A (en) 1984-04-06 2000-08-08 Chiron Corporation Secreted viral proteins useful for vaccines and diagnostics
FR2773156B1 (fr) 1997-12-26 2000-03-31 Biovacs Inc Nouveaux immunogenes anti-retroviraux (toxoides), nouveaux procedes de preparation et application a la prevention et au traitement du sida
ATE320792T1 (de) 2000-09-28 2006-04-15 Chiron Corp Mikropartikel zur verabreichung von heterologen nukleinsäure
EP1333858B8 (en) * 2000-11-07 2006-06-14 Immunovaccine Technologies Inc. Vaccines with enhanced immune response and methods for their preparation
US7303881B2 (en) * 2004-04-30 2007-12-04 Pds Biotechnology Corporation Antigen delivery compositions and methods of use

Also Published As

Publication number Publication date
WO2005049080B1 (fr) 2005-09-01
US7344720B2 (en) 2008-03-18
CA2545086C (en) 2011-11-08
SI1696954T1 (sl) 2009-04-30
EP1696954B1 (fr) 2008-10-29
CN1882358A (zh) 2006-12-20
DK1696954T3 (da) 2009-02-23
KR101136107B1 (ko) 2012-04-17
JP4638880B2 (ja) 2011-02-23
LT2006036A (en) 2007-05-25
FR2862306A1 (fr) 2005-05-20
IL175573A0 (en) 2006-09-05
CY1108498T1 (el) 2014-04-09
AU2004290943B2 (en) 2009-08-27
LT5435B (lt) 2007-07-25
FR2862306B1 (fr) 2008-05-30
CN1882358B (zh) 2011-02-02
IL175573A (en) 2010-06-30
ES2311875T3 (es) 2009-02-16
WO2005049080A1 (fr) 2005-06-02
EP1696954A1 (fr) 2006-09-06
ZA200603522B (en) 2007-07-25
ATE412429T1 (de) 2008-11-15
LV13457B (en) 2007-01-20
PL1696954T3 (pl) 2009-04-30
BRPI0416670A (pt) 2007-02-13
US20050208060A1 (en) 2005-09-22
DE602004017504D1 (de) 2008-12-11
AU2004290943A1 (en) 2005-06-02
KR20060127385A (ko) 2006-12-12
JP2007511585A (ja) 2007-05-10
US7767658B2 (en) 2010-08-03
US20080131446A1 (en) 2008-06-05
CA2545086A1 (en) 2005-06-02
PT1696954E (pt) 2008-11-25

Similar Documents

Publication Publication Date Title
NO20062779L (no) Vaksinesammensetning blandet med en alkylfosfatidylkolin
CY1108823T1 (el) Παραγωγα 2-υδροξυ-3-ετεροαρυλινδολης ως αναστολεις της gsk3
CY1115719T1 (el) Νεοι φαρμακευτικοι συνδυασμοι για τη θεραπεια νοσων των αναπνευστικων οδων
BR0010555A (pt) Inibidores de neuraminidases
EA200501098A1 (ru) Антибактериальные агенты
CY1108295T1 (el) Παραγωγα μονοσακχαριτη αβερμεκτινης τα οποια εχουν παρασιτοκτονες ιδιοτητες
BRPI0617918B8 (pt) compostos de fórmula (i) e seu uso, medicamentos e composição farmacêutica
CY1110694T1 (el) Μεθοδος παρασκευης παραγωγων της εχινοκανδινης
BRPI0616659A8 (pt) droga terapêutica antituberculose, medicamento, e, kit para o tratamento de tuberculose
ES2149305T3 (es) Compuestos de dibenzoxazepina sustituidos, composiciones farmaceuticas y procedimientos de uso.
BRPI0406824A (pt) Indolonaoxazoldinonas antiibacterianas, intermediários para seu preparo e composições farmacêuticas que as contêm
ES2162916T3 (es) Derivados de acido pirimidin- o triazincarboxilico para el empleo como medicamentos.
BRPI0407968A (pt) derivados de oxamida úteis como inibidores de raf-quinase
ECSP045396A (es) Proceso para preparar derivados de 6-alquiliden penem
AR004004A1 (es) Benzoilguanidinas sustituida, procedimiento para su preparacion, su utilizacion como medicamento o agente de diagnostico, asi como medicamento quelas contiene.
ECSP045405A (es) Penems 6-alquiliden heterotriciclil como inhibidores de la beta lactamasa
BR0312385A (pt) Preparação, processos para produzir a mesma e uma ração contendo diformiato e/ou aditivo de ração, uso de uma preparação, e, ração animal
EE200200599A (et) Tsüklipostiiniühend kasutamiseks diabeedivastase ravimina, seda sisaldav farmatseutiline preparaat,ühendi ja preparaadi valmistamine ning selleks vajalik mikroorganism
PT1123937E (pt) Substancia gm-95 processo para a sua preparacao e a sua utilizacao
BR0213633A (pt) Método e composto para tratar de uma doença associada com recrutamento e/ou ativação aberrante de leucócitos
EA200000374A2 (ru) Новые соединения 2,3-метаноаминокислоты, способ их получения и содержащие их фармацевтические композиции
AR031712A1 (es) Metodo y composicion
AR032724A1 (es) Compuestos ester, metodos de control de plagas y aplicaciones de los compuestos ester
ES2109715T3 (es) Procedimiento para la preparacion de n-carbonilariliminas utiles en la sintesis de taxoides terapeuticamente activos.
AR016261A1 (es) Compuestos de eter de morfolino, proceso para su preparacion, uso para la preparacion de medicamentos, composicion farmaceutica

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application